| High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load TC Tseng, CJ Liu, HC Yang, TH Su, CC Wang, CL Chen, SFT Kuo, ... Gastroenterology 142 (5), 1140-1149. e3, 2012 | 692 | 2012 |
| Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads TC Tseng, CJ Liu, HC Yang, TH Su, CC Wang, CL Chen, CA Hsu, ... Hepatology 57 (2), 441-450, 2013 | 328 | 2013 |
| Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters TC Tseng, CJ Liu, TH Su, CC Wang, CL Chen, PJ Chen, DS Chen, ... Gastroenterology 141 (2), 517-525. e2, 2011 | 255 | 2011 |
| Determinants of spontaneous surface antigen loss in hepatitis B e antigen–negative patients with a low viral load TC Tseng, CJ Liu, HC Yang, TH Su, CC Wang, CL Chen, S Fang‐Tzu Kuo, ... Hepatology 55 (1), 68-76, 2012 | 207 | 2012 |
| Clinical utility of quantitative HBsAg in natural history and nucleos (t) ide analogue treatment of chronic hepatitis B: new trick of old dog TC Tseng, JH Kao Journal of gastroenterology 48, 13-21, 2013 | 165 | 2013 |
| Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers TC Tseng, CJ Liu, HC Yang, CL Chen, WT Yang, CS Tsai, SFT Kuo, ... Gut 64 (2), 292-302, 2015 | 146 | 2015 |
| High level of hepatitis B core–related antigen associated with increased risk of hepatocellular carcinoma in patients with chronic HBV infection of intermediate viral load TC Tseng, CJ Liu, CY Hsu, CM Hong, TH Su, WT Yang, CL Chen, ... Gastroenterology 157 (6), 1518-1529. e3, 2019 | 129 | 2019 |
| Effect of Host and Viral Factors on Hepatitis BE Antigen-Positive Chronic Hepatitis B Patients Receiving Pegylated Interferon-α-2A Therapy TC Tseng, ML Yu, CJ Liu, CL Lin, YW Huang, CS Hsu, CH Liu, SFT Kuo, ... Antiviral therapy 16 (5), 629-637, 2011 | 107 | 2011 |
| Immunopathogenesis of hepatitis B virus TC Tseng, LR Huang The Journal of infectious diseases 216 (suppl_8), S765-S770, 2017 | 96 | 2017 |
| Risk Stratification of Hepatocellular Carcinoma in Hepatitis B Virus e Antigen–Negative Carriers by Combining Viral Biomarkers TC Tseng, CJ Liu, CL Chen, HC Yang, TH Su, CC Wang, WT Yang, ... The Journal of infectious diseases 208 (4), 584-593, 2013 | 69 | 2013 |
| Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters TC Tseng, CJ Liu, CL Chen, CC Wang, TH Su, SFT Kuo, PJ Chen, ... Journal of Infectious Diseases 205 (1), 54-63, 2012 | 69 | 2012 |
| Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon‐induced hepatitis B e antigen seroconversion HC Yang, CL Chen, YC Shen, CY Peng, CJ Liu, TC Tseng, TH Su, ... Hepatology 57 (3), 934-943, 2013 | 67 | 2013 |
| Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection TC Tseng, CJ Liu, CL Chen, WT Yang, HC Yang, TH Su, CC Wang, ... Alimentary pharmacology & therapeutics 41 (10), 949-960, 2015 | 66 | 2015 |
| Treating immune‐tolerant hepatitis B TC Tseng, JH Kao Journal of viral hepatitis 22 (2), 77-84, 2015 | 64 | 2015 |
| HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis TC Tseng, CJ Liu, CT Chang, TH Su, WT Yang, CH Tsai, CL Chen, ... Journal of hepatology 72 (6), 1105-1111, 2020 | 58 | 2020 |
| Young chronic hepatitis B patients with nucleos (t) ide analogue-induced hepatitis B e antigen seroconversion have a higher risk of HBV reactivation TC Tseng, CJ Liu, TH Su, HC Yang, CC Wang, CL Chen, SFT Kuo, ... The Journal of infectious diseases 206 (10), 1521-1531, 2012 | 56 | 2012 |
| Fibrosis-4 index helps identify HBV carriers with the lowest risk of hepatocellular carcinoma TC Tseng, CJ Liu, TH Su, WT Yang, CL Chen, HC Yang, CC Wang, ... Official journal of the American College of Gastroenterology| ACG 112 (10 …, 2017 | 53 | 2017 |
| Elimination of hepatitis B: is it a mission possible? TC Tseng, JH Kao BMC medicine 15, 1-5, 2017 | 44 | 2017 |
| Peginterferon α in the treatment of chronic hepatitis B TC Tseng, JH Kao, DS Chen Expert opinion on biological therapy 14 (7), 995-1006, 2014 | 33 | 2014 |
| Hepatitis B core-related antigen stratifies the risk of liver cancer in HBeAg-negative patients with indeterminate phase TC Tseng, T Hosaka, CJ Liu, F Suzuki, CM Hong, H Kumada, WT Yang, ... Official journal of the American College of Gastroenterology| ACG 117 (5 …, 2022 | 32 | 2022 |